| STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response M Sadrkhanloo, M Entezari, S Orouei, M Ghollasi, S Rezaei, ES Hejazi, ... Pharmacological research 182, 106311, 2022 | 119 | 2022 |
| EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions M Hashemi, HZ Arani, S Orouei, S Fallah, A Ghorbani, M Khaledabadi, ... Biomedicine & Pharmacotherapy 155, 113774, 2022 | 99 | 2022 |
| Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance M Ashrafizadeh, H Saebfar, MH Gholami, K Hushmandi, A Zabolian, ... Expert opinion on drug delivery 19 (4), 355-382, 2022 | 65 | 2022 |
| Targeting PI3K/Akt signaling in prostate cancer therapy M Hashemi, A Taheriazam, P Daneii, A Hassanpour, A Kakavand, ... Journal of Cell Communication and Signaling 17 (3), 423-443, 2023 | 49 | 2023 |
| Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy MDA Paskeh, H Saebfar, MK Mahabady, S Orouei, K Hushmandi, ... Life Sciences 298, 120463, 2022 | 30 | 2022 |
| Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers M Entezari, GGY Abad, B Sedghi, R Ettehadi, S Asadi, R Beiranvand, ... Environmental Research 225, 115673, 2023 | 27 | 2023 |
| Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions M Hashemi, HZ Arani, S Orouei, E Rostamnejad, A Ghorbani, ... Pharmacological research 185, 106475, 2022 | 21 | 2022 |
| MicroRNAs regulating SOX2 in cancer progression and therapy response S Mirzaei, H Saebfar, MH Gholami, F Hashemi, A Zarrabi, A Zabolian, ... Expert reviews in molecular medicine 23, e13, 2021 | 21 | 2021 |
| Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: mechanisms of initiation, progression, and drug sensitivity MK Mahabady, S Mirzaei, H Saebfar, MH Gholami, A Zabolian, ... Journal of Cellular Physiology 237 (5), 2309-2344, 2022 | 15 | 2022 |
| The pharmacological and biological importance of EZH2 signaling in lung cancer M Entezari, A Taheriazam, MDA Paskeh, E Sabouni, MA Zandieh, ... Biomedicine & Pharmacotherapy 160, 114313, 2023 | 11 | 2023 |
| Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets M Hashemi, S Mirzaei, MA Zandieh, S Rezaei, A Dehghanpour, ... Progress in biophysics and molecular biology 177, 207-228, 2023 | 10 | 2023 |
| Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery M Hashemi, R Aparviz, M Beickzade, MDA Paskeh, SK Kheirabad, ... Biomedicine & Pharmacotherapy 169, 115927, 2023 | 8 | 2023 |
| Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy M Deldar Abad Paskeh, H Saebfar, MK Mahabady, S Orouei, ... | | 2022 |
